Microdose Announces Industry Report + IP - Patents Report with MagicMed, Zuber Lawler, Psygen, Mydecine and Numinus

By: Issuewire

Toronto, Jan 11, 2021 (Issuewire.com) - Microdose Psychedelic Insights, the global leader in B2B psychedelic intelligence, announced the upcoming launch of their signature Microdose Psychedelic Industry Report. This 500+ page investment-grade market intelligence guide will be launched at the end of quarter one this year in addition to Microdose's Psychedelic Industry Online Directory and IP & Patents special report.

In an effort to aid stakeholders within the emerging psychedelic industry, the Industry Report includes 10k+ industry data points and covers key insights, market data, sector fundamentals, transactions, clinical trials, and important research pertaining to psychedelic medicine. 

The report will be distributed to Microdoses's internal database of industry insiders plus report aggregators that reach a massive audience. Likewise, the report will draw on connections from The Conscious Fund, a global early-stage venture fund investing in psychedelic medicine, to reach the following demographics: institutions (i.e. investment banks, hedge funds), venture capital, private equity, M&A, bank analysts, family offices, high net worths, retail, biosciences, and pharmaceuticals. 

Sponsors of the report include the most vital organizations in the psychedelic community, such as MagicMed Industries, Zuber Lawler, Psygens Labs, Mydecine Innovations Group, and Numinus. Information about the aforementioned companies is instrumental for investors, clinicians, and psychedelic enthusiasts alike.

The report will be launched alongside a psychedelic industry online directory and a special IP & patents report. The latter features vital information regarding intellectual property and the patentability of novel psychedelic compounds, delivery mechanisms, etc. 

"The mainstream acceptance of psychedelic medicine hinges on our ability to communicate their risks and benefits in a responsible and truthful manner," said Patrick Moher, CEO of Microdose. "We are proud to be publishing this industry report that has been months in the making, with a special thank you to the team of contributors that worked tirelessly to create this incredibly comprehensive industry report, which we believe to be one of the most comprehensive global psychedelic industry reports available today." 

If you are interested in sponsorship opportunities, please contact Christina@microdose.buzz.

About Microdose

Microdose Psychedelic Insights aims to unlock the potential of psychedelics through Industry events, market intelligence, original, evidence-based content, strategy, and community. We enable and empower society at large to make better, more mindful decisions about psychedelics and their intersection with healthcare, medicine, and personal growth. We work with the industry's most influential stakeholders, some of the world's best-known brands, and an unrivaled network of scientists, researchers, analysts, innovators, investors, and advisors.



Media Contact

Microdose Psychedelic Insights


kristina@microdose.buzz

https://microdose.buzz

Source :Microdose Psychedelic Insights

This article was originally published by IssueWire. Read the original article here.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.